Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT06267326
  4. Details
NCT06267326 Clinical Trial

World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

COVID-19 Clinical Trial

Official title:
Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06267326
Other study ID # Nasser institute
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date May 23, 2021
Est. completion date August 21, 2023

Study information
Verified date February 2024
Source Nasser Institute For Research and Treatment
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objectives: identify and recognize clinical Characteristics, Pathophysiology, and management of a group of patients with rhino Rhino-Orbito-Cerebral Mucormycosis infection associated with Covid 19 viral infection

Recruitment information / eligibility
Status Completed
Enrollment 35
Est. completion date August 21, 2023
Est. primary completion date June 12, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years to 77 Years
Eligibility Inclusion Criteria: - all patients with mucormycosis post covid 19 Exclusion Criteria: - The patient not suffered from covid 19

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• debridment
resection of dead bone

Locations
Country Name City State
Egypt Omar Elmonofy Cairo

Sponsors (1)
Lead Sponsor Collaborator
Nasser Institute For Research and Treatment

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary 35 patients suffering from mucormycosis infection post covid 19 Ratio Scale. Visual Analog Score for pain Ratio Scale. Ratio Scale. ratio scale 2 years
Primary 25 patients were cured with comorbidity and 10 pateints died ordinal scale Visual Analog Score for pain 2 years
Primary pain Visual Analog Score for pain two years
Secondary Visual Analog Score for pain pain 2years
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure